Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112194954 | 11219495 | 4 | F | 20150604 | 20160623 | 20150625 | 20160708 | EXP | US-ELI_LILLY_AND_COMPANY-US201506005784 | ELI LILLY AND CO | 64.16 | YR | M | Y | 63.00000 | KG | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112194954 | 11219495 | 1 | PS | FORTEO | TERIPARATIDE | 1 | Subcutaneous | 20 UG, QD | Y | U | C329597C | 21318 | 20 | UG | INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112194954 | 11219495 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112194954 | 11219495 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112194954 | 11219495 | Atrial fibrillation | |
| 112194954 | 11219495 | Dizziness | |
| 112194954 | 11219495 | Dysuria | |
| 112194954 | 11219495 | Fatigue | |
| 112194954 | 11219495 | Feeling abnormal | |
| 112194954 | 11219495 | Heart rate increased | |
| 112194954 | 11219495 | Lethargy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112194954 | 11219495 | 1 | 20150604 | 20150604 | 0 |